February 2025 - InRAD receives funding from Bristol Myers Squibb

InRAD is thrilled to announce that it has received funding from Bristol Myers Squibb to support its ongoing registry efforts. This contribution will be directed towards the next phase of building the registry platform.

We extend our thanks to all our partners for their unwavering support and collaboration. This funding marks an important milestone in our journey, and we are excited about the advancements it will bring. For more information on how you can get involved, please contact us on info@InRADnetwork.org

About InRAD

An international, practice-based registry for Alzheimer’s Disease and other dementias. Providing collaborative database tools and research capabilities to support patient care and advance knowledge through epidemiological and outcomes studies.